FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

396064000: Fluticasone propionate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1470004013 Fluticasone propionate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489689017 Fluticasone propionate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
11431000188116 fluticasone propionate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
812961000172111 propionate de fluticasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluticasone propionate (substance) Is a Anti-inflammatory agent false Inferred relationship Some
Fluticasone propionate (substance) Is a Fluticasone (substance) false Inferred relationship Some
Fluticasone propionate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Fluticasone (substance) true Inferred relationship Some
Fluticasone propionate (substance) Is a corticostéroïde pour administration pulmonaire false Inferred relationship Some
Fluticasone propionate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen receptor agonist (disposition) false Inferred relationship Some
Fluticasone propionate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadal hormone false Inferred relationship Some
Fluticasone propionate (substance) Is a Androstane true Inferred relationship Some
Fluticasone propionate (substance) Is a Fluorinated corticosteroid true Inferred relationship Some
Fluticasone propionate (substance) Is a Glucocorticoid (substance) true Inferred relationship Some
Fluticasone propionate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate topical preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate [respiratory use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 100micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 250micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 100micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 250micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 25micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 125micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 250micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 500micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 500micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 500micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 0.5mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 2mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50micrograms aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 400micrograms single-use nasal drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate[skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 500 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 44mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 110mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 220mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 0.05% spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 9g spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 110mcg powder for inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 44mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 110mcg/spray aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 110mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 220mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 220mcg/spray aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 44mcg/inh aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 125mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 250mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 50mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Respiratory fluticasone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Product containing fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Product containing fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone propionate (substance) Inferred relationship Some
Fluticasone propionate 500 microgram/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 500 microgram/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/g cutaneous ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/g cutaneous ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/actuation nasal spray The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/actuation nasal spray This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 125 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 125 microgram/actuation pressurized suspension for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 250 microgram/actuation powder for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 250 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 100 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 100 microgram/actuation powder for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 250 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 25 microgram/actuation pressurized suspension for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 500 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 500 microgram/actuation powder for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/actuation powder for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fluticasone propionate (substance) Inferred relationship Some 1
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 2
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 2
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 2
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 2
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fluticasone propionate (substance) Inferred relationship Some 2
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 2
Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fluticasone propionate (substance) Inferred relationship Some 2

Page 1 of 2 End


Reference Sets

GB English

US English

Back to Start